A Phase III trial of radiation therapy with or without Casodex in patients with PSA [prostate specific antigen] elevation following radical prostatectomy for pT3N0 carcinoma of the prostate

Trial Profile

A Phase III trial of radiation therapy with or without Casodex in patients with PSA [prostate specific antigen] elevation following radical prostatectomy for pT3N0 carcinoma of the prostate

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 25 May 2017

At a glance

  • Drugs Bicalutamide (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jun 2013 Planned End Date changed to 1 Dec 2016.
    • 19 Feb 2011 Seven-year results presented at the 2011 Genitourinary Cancers Symposium.
    • 15 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top